Michael Xavier Doss

2.2k total citations · 1 hit paper
40 papers, 1.3k citations indexed

About

Michael Xavier Doss is a scholar working on Molecular Biology, Surgery and Biomedical Engineering. According to data from OpenAlex, Michael Xavier Doss has authored 40 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 6 papers in Surgery and 6 papers in Biomedical Engineering. Recurrent topics in Michael Xavier Doss's work include Pluripotent Stem Cells Research (27 papers), CRISPR and Genetic Engineering (14 papers) and Congenital heart defects research (6 papers). Michael Xavier Doss is often cited by papers focused on Pluripotent Stem Cells Research (27 papers), CRISPR and Genetic Engineering (14 papers) and Congenital heart defects research (6 papers). Michael Xavier Doss collaborates with scholars based in Germany, United States and Estonia. Michael Xavier Doss's co-authors include Agapios Sachinidis, Jürgen Hescheler, Charles Antzelevitch, Cornelia Gissel, Johannes Winkler, Christoph Koehler, John Antonydas Gaspar, José M. Di Diego, Jonathan M. Cordeiro and Jacqueline A. Treat and has published in prestigious journals such as PLoS ONE, Circulation Research and Scientific Reports.

In The Last Decade

Michael Xavier Doss

39 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications

2019 306 citations Michael Xavier Doss, Agapios Sachinidis Cells profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Xavier Doss Germany	18	983	252	242	207	176	40	1.3k
Chantal Allamargot United States	16	1.0k 1.0×	135 0.5×	144 0.6×	126 0.6×	248 1.4×	27	1.6k
Heming Wei Singapore	21	804 0.8×	315 1.3×	235 1.0×	130 0.6×	355 2.0×	52	1.3k
Mohamed Ameen United States	15	771 0.8×	212 0.8×	127 0.5×	145 0.7×	275 1.6×	23	1.0k
Chi Keung Lam United States	19	993 1.0×	158 0.6×	189 0.8×	131 0.6×	633 3.6×	34	1.4k
Gwanghyun Jung United States	15	866 0.9×	178 0.7×	296 1.2×	100 0.5×	226 1.3×	16	1.3k
Karim Sallam United States	18	1.1k 1.1×	329 1.3×	287 1.2×	331 1.6×	536 3.0×	51	1.6k
Connie S. Lebakken United States	16	826 0.8×	77 0.3×	143 0.6×	154 0.7×	117 0.7×	23	1.1k
Ka‐Wing Au Hong Kong	19	659 0.7×	191 0.8×	125 0.5×	113 0.5×	249 1.4×	31	943
Matthew Klos United States	15	829 0.8×	387 1.5×	288 1.2×	228 1.1×	662 3.8×	26	1.5k
Li Pang United States	19	621 0.6×	132 0.5×	240 1.0×	149 0.7×	861 4.9×	47	1.6k

Countries citing papers authored by Michael Xavier Doss

Since Specialization

Citations

This map shows the geographic impact of Michael Xavier Doss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Xavier Doss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Xavier Doss more than expected).

Fields of papers citing papers by Michael Xavier Doss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Xavier Doss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Xavier Doss. The network helps show where Michael Xavier Doss may publish in the future.

Co-authorship network of co-authors of Michael Xavier Doss

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Xavier Doss. A scholar is included among the top collaborators of Michael Xavier Doss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Xavier Doss. Michael Xavier Doss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ismail, Ashrafali Mohamed, Bridget Yates, Lin Xie, et al.. (2022). Vector genome loss and epigenetic modifications mediate decline in transgene expression of AAV5 vectors produced in mammalian and insect cells. Molecular Therapy. 30(12). 3570–3586. 30 indexed citations

Dangwal, Seema, et al.. (2021). Application of the Pluripotent Stem Cells and Genomics in Cardiovascular Research—What We Have Learnt and Not Learnt until Now. Cells. 10(11). 3112–3112. 6 indexed citations

Doss, Michael Xavier & Agapios Sachinidis. (2019). Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications. Cells. 8(5). 403–403. 306 indexed citations breakdown →

Gaspar, John Antonydas, Sureshkumar Perumal Srinivasan, P. Sureshkumar, et al.. (2017). Depletion of Mageb16 induces differentiation of pluripotent stem cells predominantly into mesodermal derivatives. Scientific Reports. 7(1). 14285–14285. 6 indexed citations

Brown, Kemar, et al.. (2017). Overexpression of Map3k7 activates sinoatrial node-like differentiation in mouse ES-derived cardiomyocytes. PLoS ONE. 12(12). e0189818–e0189818. 7 indexed citations

Sabour, Davood, Sureshkumar Perumal Srinivasan, Vilas Wagh, et al.. (2017). STRIP2 Is Indispensable for the Onset of Embryonic Stem Cell Differentiation. Molecular Therapy — Methods & Clinical Development. 5. 116–129. 16 indexed citations

Gabdoulline, Razif, Wolfgang Kaisers, Ana Gaspar, et al.. (2015). Differences in the Early Development of Human and Mouse Embryonic Stem Cells. PLoS ONE. 10(10). e0140803–e0140803. 13 indexed citations

Burashnikov, Alexander, José M. Di Diego, Serge Sicouri, et al.. (2014). A Temporal Window of Vulnerability for Development of Atrial Fibrillation with Advancing Heart Failure. European Journal of Heart Failure. 16(3). 271–280. 14 indexed citations

Wagh, Vasant, Michael Xavier Doss, Davood Sabour, et al.. (2014). Fam40b is required for lineage commitment of murine embryonic stem cells. Cell Death and Disease. 5(7). e1320–e1320. 17 indexed citations

10.

Cordeiro, Jonathan M., Vladislav V. Nesterenko, Serge Sicouri, et al.. (2013). Identification and characterization of a transient outward K+ current in human induced pluripotent stem cell-derived cardiomyocytes. Journal of Molecular and Cellular Cardiology. 60. 36–46. 52 indexed citations

11.

Gaspar, John Antonydas, Michael Xavier Doss, Johannes Winkler, et al.. (2012). Gene Expression Signatures Defining Fundamental Biological Processes in Pluripotent, Early, and Late Differentiated Embryonic Stem Cells. Stem Cells and Development. 21(13). 2471–2484. 17 indexed citations

12.

Doss, Michael Xavier, John Antonydas Gaspar, Johannes Winkler, et al.. (2011). Specific Gene Signatures and Pathways in Mesodermal Cells and Their Derivatives Derived from Embryonic Stem Cells. Stem Cell Reviews and Reports. 8(1). 43–54. 16 indexed citations

13.

Conesa, Celia, Michael Xavier Doss, Charles Antzelevitch, et al.. (2011). Identification of Specific Pluripotent Stem Cell Death—Inducing Small Molecules by Chemical Screening. Stem Cell Reviews and Reports. 8(1). 116–127. 16 indexed citations

14.

Brown, Kemar, Jérôme Artus, Michael Xavier Doss, et al.. (2010). A Comparative Analysis of Extra-Embryonic Endoderm Cell Lines. PLoS ONE. 5(8). e12016–e12016. 45 indexed citations

15.

Brown, Kemar, et al.. (2010). eXtraembryonic ENdoderm (XEN) Stem Cells Produce Factors that Activate Heart Formation. PLoS ONE. 5(10). e13446–e13446. 29 indexed citations

16.

Doss, Michael Xavier, et al.. (2010). Induced Pluripotent Stem Cells as a Model for Accelerated Patient- and Disease-specific Drug Discovery. Current Medicinal Chemistry. 17(8). 759–766. 75 indexed citations

17.

Doss, Michael Xavier, Johannes Winkler, Shuhua Chen, et al.. (2007). Global transcriptome analysis of murine embryonic stem cell-derived cardiomyocytes. Genome biology. 8(4). R56–R56. 50 indexed citations

18.

Winkler, Johannes, et al.. (2006). Dietary Small Molecules and Large-Scale Gene Expression Studies: An Experimental Approach for Understanding their Beneficial Effects on the Development of Malignant and Non-Malignant Proliferative Diseases. Current Medicinal Chemistry. 13(13). 1481–1489. 10 indexed citations

19.

Doss, Michael Xavier, et al.. (2005). Trapping of growth factors by catechins: a possible therapeutical target for prevention of proliferative diseases. The Journal of Nutritional Biochemistry. 16(5). 259–266. 55 indexed citations

20.

Doss, Michael Xavier, Christoph Koehler, Cornelia Gissel, Jürgen Hescheler, & Agapios Sachinidis. (2004). Embryonic stem cells: a promising tool for cell replacement therapy. Journal of Cellular and Molecular Medicine. 8(4). 465–473. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact